Vapiwala Neha, Hwang Wei-Ting, Kushner Carolyn J, Schnall Mitchell D, Freedman Gary M, Solin Lawrence J
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer. 2017 Apr 15;123(8):1324-1332. doi: 10.1002/cncr.30479. Epub 2016 Dec 16.
For women undergoing breast conservation therapy (BCT), the added value of breast magnetic resonance imaging (MRI) at the time of initial diagnosis remains controversial. The current study was performed to determine long-term outcomes after BCT for women with and without pretreatment breast MRI.
Between 1992 and 2001, a total of 755 women with ductal carcinoma in situ or early-stage invasive breast cancer underwent breast-conserving surgery (with axillary lymph node staging for invasive carcinoma) followed by definitive breast radiotherapy. Evaluation at the time of the initial diagnosis included conventional mammography in all subjects and breast MRI in 215 women (28%). Clinical, pathologic, and treatment characteristics were comparable for patients with and without breast MRI. Outcomes were determined using the Kaplan-Meier method and compared using the log-rank method.
At a median follow-up of 13.8 years, there were 49 local failures (15 women with and 34 women without breast MRI, respectively). The 15-year local failure rates were 8% for women with and 8% for women without MRI (P = .59). There also were no differences noted between women with and without breast MRI with regard to 15-year rates of overall survival (77% vs 71%; P = .24), freedom from distant metastases (86% vs 90%; P = .08), and contralateral breast cancer (10% vs 8%; P = .10). Multivariate analysis demonstrated no significant impact of breast MRI on local failure (P = .96).
Breast MRI during the initial evaluation for BCT appears to have no significant impact on 15-year rates for local control, overall survival, freedom from distant metastases, or contralateral breast cancer. The routine use of pretreatment breast MRI is not indicated for patients undergoing BCT. Cancer 2017;123:1324-1332. © 2016 American Cancer Society.
对于接受保乳治疗(BCT)的女性,初次诊断时乳腺磁共振成像(MRI)的附加价值仍存在争议。本研究旨在确定接受BCT治疗的女性在有或没有术前乳腺MRI检查情况下的长期预后。
1992年至2001年间,共有755例导管原位癌或早期浸润性乳腺癌女性接受了保乳手术(浸润性癌患者进行腋窝淋巴结分期),随后进行了确定性乳腺放疗。初次诊断时的评估包括所有受试者的常规乳腺X线摄影以及215例女性(28%)的乳腺MRI检查。有或没有乳腺MRI检查的患者在临床、病理和治疗特征方面具有可比性。使用Kaplan-Meier方法确定预后,并使用对数秩检验进行比较。
中位随访13.8年时,发生了49例局部复发(分别为15例有乳腺MRI检查的女性和34例没有乳腺MRI检查的女性)。有MRI检查的女性15年局部复发率为8%,没有MRI检查的女性为8%(P = 0.59)。在15年总生存率(77%对71%;P = 0.24)、无远处转移率(86%对90%;P = 0.08)和对侧乳腺癌发生率(10%对8%;P = 0.10)方面,有或没有乳腺MRI检查的女性之间也未发现差异。多因素分析表明乳腺MRI对局部复发没有显著影响(P = 0.96)。
BCT初次评估时的乳腺MRI似乎对15年局部控制率、总生存率、无远处转移率或对侧乳腺癌发生率没有显著影响。对于接受BCT的患者,不建议常规使用术前乳腺MRI检查。《癌症》2017年;123:1324 - 1332。©2016美国癌症协会。